tiprankstipranks
Xenon Pharmaceuticals Reports Q3 2024 Progress and Outlook
PremiumCompany AnnouncementsXenon Pharmaceuticals Reports Q3 2024 Progress and Outlook
1M ago
Xenon Advances Epilepsy and Depression Programs
Premium
Company Announcements
Xenon Advances Epilepsy and Depression Programs
1M ago
Xenon Pharmaceuticals reports Q3 EPS (81c), consensus (81c)
Premium
The Fly
Xenon Pharmaceuticals reports Q3 EPS (81c), consensus (81c)
1M ago
Xenon Pharmaceuticals to Present at CNS Virtual Conference
PremiumCompany AnnouncementsXenon Pharmaceuticals to Present at CNS Virtual Conference
3M ago
Xenon Pharmaceuticals initiated with a Buy at H.C. Wainwright
Premium
The Fly
Xenon Pharmaceuticals initiated with a Buy at H.C. Wainwright
3M ago
Xenon’s Azetukalner Marks Success in Epilepsy Treatment
Premium
Company Announcements
Xenon’s Azetukalner Marks Success in Epilepsy Treatment
3M ago
Xenon Pharmaceuticals price target lowered to $49 from $50 at Wedbush
PremiumThe FlyXenon Pharmaceuticals price target lowered to $49 from $50 at Wedbush
4M ago
Xenon Pharma Engages Audience Across Multiple Platforms
Premium
Company Announcements
Xenon Pharma Engages Audience Across Multiple Platforms
4M ago
Xenon Pharmaceuticals reports Q2 EPS (75c), consensus (70c)
Premium
The Fly
Xenon Pharmaceuticals reports Q2 EPS (75c), consensus (70c)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100